SCHEMBL23584569

SCHEMBL23584569

Nc1ncnn2c([C@H]3CC[C@@H](CN4CCC(F)(F)C[C@H]4CN4CCCC4)O3)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584487 0.87 — —
SCHEMBL23584590 0.87 DOT1L (0.32) —
SCHEMBL23584801 0.87 POLRMT (0.32) —
SCHEMBL23584730 0.83 EGLN2 (0.30) —
SCHEMBL19344169 0.82 POLRMT (0.35) —
SCHEMBL19344160 0.82 POLRMT (0.35) —
SCHEMBL23584490 0.82 — —
SCHEMBL19344174 0.82 POLRMT (0.32) —
SCHEMBL23584486 0.80 DOT1L (0.33) —
SCHEMBL19344281 0.80 POLRMT (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback